Provided by Tiger Trade Technology Pte. Ltd.

CSTONE PHARMA-B

6.080
-0.085-1.38%
Volume:22.34M
Turnover:137.17M
Market Cap:9.70B
PE:-19.32
High:6.360
Open:6.165
Low:5.970
Close:6.165
52wk High:11.190
52wk Low:4.010
Shares:1.60B
HK Float Shares:1.60B
Volume Ratio:1.14
T/O Rate:1.40%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.315
ROE:-52.14%
ROA:-14.44%
PB:6.43
PE(LYR):-19.32
PS:19.54

Loading ...

CStone Pharmaceuticals-B Executes Share Buyback on June 25

Stock News
·
Jun 26

Cstone Pharmaceuticals Files HKEX Next-day Disclosure Return on Share Repurchase for Cancellation

Reuters
·
Jun 26

CStone Pharma Taps Arrotex to Commercialize Sugemalimab in Australia, New Zealand

MT Newswires Live
·
Jun 26

Hong Kong Market Announcement Highlights: Six Companies Including Keytop Parking and WENGE AI List Today; Bosideng Annual Profit Attributable to Shareholders Rises 13.7% to Approximately RMB 39.94 Billion

Stock News
·
Jun 26

New Energy System Blueprint and Rural EV Initiative Unveiled as Key Stocks Report Earnings

Stock News
·
Jun 26

CStone Pharma repurchases 4.18 million shares, equal to 0.26 % of outstanding capital

Bulletin Express
·
Jun 25

Cstone Pharmaceuticals - to Receive Upfront Payment, Milestone Payments, and Profit Share from Arrotex

THOMSON REUTERS
·
Jun 25

Cstone Pharmaceuticals - Enters Exclusive Commercialization Agreement with Arrotex for Sugemalimab in Australia and New Zealand

THOMSON REUTERS
·
Jun 25

CStone Pharma buys back 0.50 million shares on 24 June; cumulative un-cancelled repurchases reach 3.84 million

Bulletin Express
·
Jun 24

CStone Pharmaceuticals-B Executes Share Buyback, Spending HK$2.4 Million

Stock News
·
Jun 24

Cstone Files HKEX Next-day Disclosure Return on Share Repurchase for Cancellation

Reuters
·
Jun 24

CStone Pharmaceuticals: All AGM Resolutions Secure Shareholder Approval; CEO Equity Incentive Plan Backed by 86.94% of Votes

Bulletin Express
·
Jun 24

CStone Pharmaceuticals shareholders pass AGM resolutions

Reuters
·
Jun 24

CSTONE PHARMA-B Repurchases 500,000 Shares for HK$2.35 Million

Stock News
·
Jun 22

CStone Pharmaceuticals files HKEX next-day disclosure, reports share repurchase for cancellation

Reuters
·
Jun 22

CStone Pharmaceuticals repurchases 500,000 shares at up to HK$4.63; June buybacks total 2.84 million shares

Bulletin Express
·
Jun 18

CStone Pharmaceuticals-B Repurchases 500,000 Shares for HK$2.3143 Million on June 18

Stock News
·
Jun 18

CStone files HKEX next-day disclosure return, reports share repurchase for cancellation

Reuters
·
Jun 18

CStone Pharmaceuticals Repurchases 1.00 Million Shares on 17 June; Cumulative Buyback Reaches 2.34 Million Shares

Bulletin Express
·
Jun 17

Directors and Company Execute Major Share Purchases and Buyback at CSTONE PHARMA-B

Stock News
·
Jun 17